Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals

This publication has 23 references indexed in Scilit:

• Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
  New England Journal of Medicine, 2003
• Disorders of Glucose Metabolism in Patients Infected with Human Immunodeficiency Virus
  Clinical Infectious Diseases, 2000
• Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
  Clinical Infectious Diseases, 2000
• Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.
  Diabetes Care, 1999
• Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
  AIDS, 1999
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
  The Lancet, 1999
• Triglycerides as a risk factor for coronary artery disease
  The American Journal of Cardiology, 1998
• Protease inhibitor-associated hyperglycaemia
  The Lancet, 1997
• Fatty acid regulation of very low density lipoprotein production
  Current Opinion in Lipidology, 1997